Select Publications
Journal articles
2010, 'Lack of Y6 receptor signaling in mice results in a lean phenotype on a chow diet but exacerbated high fat diet-induced obesity', Obesity Research & Clinical Practice, 4, pp. S65 - S65, http://dx.doi.org/10.1016/j.orcp.2010.09.127
,2010, 'Mouse model of Prader–Willi syndrome: The role of SNORD116 in the regulation of energy homeostasis', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.012
,2010, 'Neuropeptide Y and sex hormone interactions in humoral and neuronal regulation of bone and fat', Trends in Endocrinology and Metabolism, 21, pp. 411 - 418
,2010, 'Neuropeptide Y in the basolateral amygdala modulates the acquisition of conditioned fear', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a33
,2010, 'NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice', PLoS One, 5, pp. e11361, http://dx.doi.org/10.1371/journal.pone.0011361
,2010, 'Peptide YY is critical for acylethanolamine receptor Gpr119-induced activation of gastrointestinal mucosal responses', Cell Metabolism, 11, pp. 532 - 542, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20519124
,2010, 'Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion', International journal of obesity, 34, pp. 357 - 373, http://dx.doi.org/10.1038/ijo.2009.232
,2010, 'Prader-willi syndrome is associated with activation of the innate immune system independently of central adiposity and insulin resistance', Journal of Clinical Endocrinology and Metabolism, 95, pp. 3392 - 3399
,2010, 'Schizophrenia-relevant behaviours in a genetic mouse model for Y2 deficiency', Behavioural Brain Research, 207, pp. 434 - 440
,2010, 'The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression', Journal of Neuroscience, 30, pp. 6282 - 6290
,2010, 'Y4 receptors and pancreatic polypeptide regulate food intake via hypothalamic orexin and brain-derived neurotropic factor dependent pathways', Neuropeptides, 44, pp. 261 - 268, http://dx.doi.org/10.1016/j.npep.2010.01.001
,2009, 'Critical interplay between neuropeptide Y and sex steroid pathways in bone and adipose tissue homeostasis', Journal of Bone and Mineral Research, 24, pp. 294 - 304
,2009, 'Critical role of arcuate Y4 receptors and the melanocortin system in pancreatic polypeptide-induced reduction in food intake in mice', PLoS One, 4, pp. 8488, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=20041129
,2009, 'Effect of neuropeptide Y Y2 receptor deletion on emotional stress-induced neuronal activation in mice', Synapse, 63, pp. 236 - 246
,2009, 'Endogenous dynorphin in emotional control and stress response', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a39
,2009, 'Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake', Neuropeptides, 43, pp. 491 - 497, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19781771
,2009, 'Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner', Behavioural Brain Research, 203, pp. 97 - 107
,2009, 'Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice', Neuroscience, 158, pp. 1717 - 1730
,2009, 'Involvement of dynorphin in anxiogenic effects of estrogen', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a9
,2009, 'Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight', PLoS Clinical Trials, 4, pp. e8415 - e
,2009, 'NPY regulation of bone remodelling', Neuropeptides, 43, pp. 457 - 463
,2009, 'NPY revealed as a critical modulator of osteoblast function in vitro: New insights into the role of Y1 and Y2 receptors', Journal of Cellular Biochemistry, 107, pp. 908 - 916
,2009, 'NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target', Current Drug Targets, 10, pp. 9 - 19
,2009, 'Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone', Neuropsychopharmacology, 34, pp. 775 - 785
,2009, 'The gut-mood axis: a novel role of the gut hormone peptide YY on emotional-affective behaviour in mice', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a13
,2009, 'The role of NPY in expression and extinction of conditioned fear', BMC Pharmacology, 9, http://dx.doi.org/10.1186/1471-2210-9-s2-a33
,2008, 'Megakaryocyte/platelet-derived Neuropeptide Y (NPY), in addition to neuronal, is essential for ischemic revascularization in rodents', FASEB JOURNAL, 22, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208467808113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes', International Journal of Obesity and Related Metabolic Disorders, 32, pp. 943 - 948, http://dx.doi.org/10.1038/ijo.2008.24
,2008, 'Behavioural characterization of prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a5
,2008, 'Behavioural profile of a new mouse model for NPY deficiency', European Journal of Neuroscience, 28, pp. 173 - 180
,2008, 'Central regulation of bone mass', Seminars in Cell and Developmental Biology, 19, pp. 452 - 458
,2008, 'Endorphins regulate bone homeostasis by actions through dynorphin', Bone, 42, pp. S43 - S44, http://dx.doi.org/10.1016/j.bone.2007.12.070
,2008, 'Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice', Neuropharmacology, 55, pp. 117 - 126
,2008, 'Increased novelty-induced motor activity and reduced depression-like behavior in NPY Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a17
,2008, 'Influence of estrous cycle on explorative behaviour of wild-type and prodynorphin knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a6
,2008, 'Long-term depression-like effect of a single immune challenge in neuropeptide Y Y2 and Y4 receptor knockout mice', BMC Pharmacology, 8, http://dx.doi.org/10.1186/1471-2210-8-s1-a39
,2008, 'Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain', Proceedings of the National Academy of Sciences of the United States of America, 105, pp. 3610 - 3615, http://dx.doi.org/10.1073/pnas.0712303105
,2008, 'PYY transgenic mice are protected against diet-induced and genetic obesity', Neuropeptides, 42, pp. 19 - 30, http://dx.doi.org/10.1016/j.npep.2007.11.003
,2008, 'Reduced anxiety-like and depression-related behavior in neuropeptide YY4 receptor knockout mice', Genes Brain and Behavior, 7, pp. 532 - 542
,2008, 'Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium', Journal of Neurochemistry, 105, pp. 641 - 652, http://dx.doi.org/10.1111/j.1471-4159.2007.05188.x
,2007, 'Y2, Y4 receptors and obesity', Expert Review of Endocrinology and Metabolism, 2, pp. 163 - 173, http://dx.doi.org/10.1586/17446651.2.2.163
,2007, 'Erratum: Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome (Nature Medicine (2007) 13, (803-811))', Nature Medicine, 13, pp. 1120, http://dx.doi.org/10.1038/nm0907-1120
,2007, 'Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome', Nature Medicine, 13, pp. 803 - 811, http://dx.doi.org/10.1038/nm1611
,2007, 'Anticonvulsant and neuroprotective actions of endogenous dynorphin', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a10
,2007, 'Behavioral profiling of NPY in aggression and neuropsychiatric diseases', Peptides, 28, pp. 326 - 333
,2007, 'Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice', Molecular Endocrinology, 21, pp. 1722 - 1735
,2007, 'Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors', Brain, 130, pp. 1017 - 1028
,2007, 'Experiments to localize the site for the anxiogenic action of NPY mediated by Y2 receptors in the mouse brain', BMC Pharmacology, 7, http://dx.doi.org/10.1186/1471-2210-7-s2-a14
,2007, 'Fasting inhibits the growth and reproductive axes via distinct Y2 and Y4 receptor-mediated pathways', Endocrinology, 148, pp. 2056 - 2065
,2007, 'Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development', Federation of American Societies for Experimantal Biology Journal, 21, pp. 2108 - 2112
,